Zobrazeno 1 - 10
of 190
pro vyhledávání: '"Stuart, Maddin"'
Autor:
Sauer, Gordon C.
Publikováno v:
Journal of Occupational Medicine, 1962 Mar 01. 4(3), 165-165.
Externí odkaz:
https://www.jstor.org/stable/44999640
Autor:
Stuart, Maddin
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 13(9)
Publikováno v:
Journal of Cutaneous Medicine and Surgery. 10:S14-S21
Sunscreens form an important modality for cutaneous photoprotection. Sunscreen formulations incorporate many features that provide protection from ultraviolet (UV)-induced carcinogenesis, immunosuppression, and accelerated photoaging. Since the 1920s
Autor:
Stuart Maddin
Publikováno v:
Journal of the American Academy of Dermatology. 40:961-965
Background: Although it is important for physicians to have sufficient clinical data on which to base treatment decisions, little comparative data exist regarding newer treatment modalities for rosacea. Objective: The goal of the study was to compare
Autor:
Richard Cloutier, Sylvia Garnis-Jones, Boni E. Elewski, Peter R. Hull, Gary R. Sibbald, H. Earl Jones, Jean-Mario Giroux, Thomas Maher, Jay E. Birnbaum, David Gratton, Stuart Maddin, Alfons L. Krol, J.Barrie Ross, Sandra Evans, Michel Journet, Ronald C. Savin, Mark Tolpin, Lynn A. Drake, Neil H. Shear, Thomas Chinv, Frederick W. Danbye, Christian Marsolais, Wayne Gulliver, James J. Leyden, Nardo Zaias, Jon P. Arlette, Richard K. Scher, Naji H. Tawfik, Tsuang-Hua Lin
Publikováno v:
Journal of the American Academy of Dermatology. 37:740-745
Background: Onychomycosis is an increasing problem with limited therapeutic options. Objective: We evaluated the safety and efficacy of oral terbinafine, a new fungicidal antimycotic, in patients with toenail onychomycosis. Methods: A North American
Autor:
Stuart Maddin
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 8:S18-S23
Background For patients with urticaria, H1-antihistamines remain the gold standard medical treatment of choice. They act by blocking H1 receptors on the vascular endothelial cell surface. Newer, non-sedating antihistamines such as loratadine also act
Publikováno v:
Journal of drugs in dermatology : JDD. 12(7)
Itraconazole, approved for treatment of toenail fungal infection onychomycosis, provides antifungal activity at a dosage requiring once-daily (QD) administration of 2 100-mg capsules for 12 weeks. Utilizing the Meltrex® technology delivery system, a
Publikováno v:
Journal of the American Academy of Dermatology. 29:1008-1012
Background: Ketoconazole is highly effective against the yeast Pityrosporum ovale, an organism believed to be involved in the pathogenesis of dandruff. Objective: Our purpose was to evaluate the safety and effectiveness of ketoconazole 2% shampoo ver
Autor:
Catriona A. Henderson, W. Stuart Maddin, Alain Claudy, Marjorie M Young, David Gratton, J. Berth-Jones, Jean-Paul Ortonne, Geoffrey Fairiss, Colin A. Holden, David Goldin, William J. Cunliffe
Publikováno v:
Journal of the American Academy of Dermatology. 26:736-743
Topical vitamin D analogues have been reported to be an effective treatment in patients with psoriasis. Comparative studies with existing treatments are required.Our purpose was to compare the effectiveness of calcipotriol (50 micrograms/gm) and beta
Autor:
Stuart Maddin
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 1:31-36